impact of the COVID-19 in the periods going forward as the situation is still evolving. It is, however, certain that Thailand and worldwide measures against spread of the COVID-19 will have adverse effects
sales. These measures are expected to enhance sales efficiency and return moving forward. • International revenues and others were Bt6,564mn decreasing 0.4% YoY from a decline in IDD service which was
forward on its Balance Sheet Strengthening Strategy and achieved a major milestone during the quarter by successfully issuing Rights Offering for THB 1,503 Million to its shareholders, which was
loss was incurred from THB depreciation against USD. In general, AIS has policy to mitigate currency risk using forward contract to partially cover capex payable Finance cost was Bt1,414mn, decreasing
, and GMO assumes no duty to and does not undertake to update forward-looking statements. Any forward-looking statements are not guarantees of any future performance and actual results or developments may
in which the Company operates. However, the Company is unable to reasonably estimate the financial negative impact of the COVID-19 in the periods going forward as the situation is still evolving. It is
, decreasing over-year, but still within the set target of 3.2-3.4 percent. However, non-interest income fell Baht 405 million, or 2.61 percent over-year due mainly to decreasing net insurance premiums. Moreover
achievements expressed or implied by such forward-looking statements. Please note that the company and executives/staff do not control and cannot guarantee the relevance, timeliness, or accuracy of these
on total sales and net profit either increasing or decreasing from changes of inventory at the end of period. In Q1/2019, the Company and its subsidiaries recorded total sales of Baht 1,302 million